King Pharmaceuticals Inc. (KG)

All Comments on KG

  • commenter
    TheOpioidTru
    th
    Oct 06 11:53 AM
    Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [view article]
    Name one that cannot be circumvented by taking excessive doses intact?-

    Aside from a pro-drug approach like NRP's which cannot be used for analgesics.     Reply
  • commenter
    user80210
    Sep 28 01:14 PM
    Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [view article]
    "Where I think they get it wrong is that all of the tamper technologies are bypassed by taking them orally, intact"

    That's where your assumptions are dead wrong. Do some homework.     Reply
  • commenter
    Mark Johnson
    Sep 18 05:26 PM
    Thursday Options Update: MS, STT, LM, NAL, GGP, PLD, KG, DO [view article]
    I think you are wrong in several aspects of describing the KG call spread. Even if the stock is above $10 at expiration, it has to be above $10.80 before the trader hits break even. Anywhere above $10.80 (to infinity even) is profitable. Even if it goes above $12.50, it will be profitable. The maximum profit is $1.70 and that profit will be had anywhere from $12.50 and above. Reply
  • commenter
    TheOpioidTru
    th
    Aug 26 09:06 AM
    Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [view article]
    Actually, this is a very well thought out article. The use of niacin as a detterent s a bone headed maneuver. Why treat all of the patients as abusers, which is what adding a pharmacological deterrent is doing? Where I think they get it wrong is that all of the tamper technologies are bypassed by taking them orally, intact. Therefore they are all faulted Take two ER 40mg to get the effect of one IR 30mg. They are right in that the FDA also will not allow label claims unless post marketing studies validate the claims. That goes for Remoxy also. Post marketing studies will take years but that helps King. I can always get 10 addicts to say that Remoxy is harder to snort than the old OxyContin. That is a study to submit. I think the key for King is to price it a cheaply as possible and pull market share. Reply
  • commenter
    tiger9844
    Aug 07 01:41 PM
    Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [view article]
    doug, Endo (Durect) is working on one however they are working on the extended release not the immediate release that Acura has put together. There are multiple competitors in this sector, but unlike most extended release versions Acura targets the immediate release market. In addition Acura's patented platform has several trailing drugs in the works and can also be applied to over the counter medicines. Oh, and the whole thing is global, not just in the U.S.

    Also, this article was taken from this bogus company's website and until they were called out last night they only had one link on the entire site which was that to this attempt to bash Acura. back is right and someone desperately wants to spread false information about Acura.     Reply
  • commenter
    back357
    Jul 24 08:31 AM
    Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [view article]
    Allegedly written by Jeffery S. Cohen and Kevin T. McNamara. Neither of which appear anywhere on Google regarding investment research. Reply
  • commenter
    Reddick
    Jul 23 11:15 PM
    Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [view article]
    Who is/are the authors of this write-up? Anybody? Reply
  • commenter
    back357
    Jul 23 04:26 PM
    Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [view article]
    The article is from a ficticious research company. Do some digging and try to find a legit researcher or firm called BioLogics, LLC. Same article was posted on Yahoo's finance message board under both King and Acura. Looks like someone is going to lose their shorts...LOL

    Old data and incorrect information. Typical example of what's wrong with the internet.     Reply
  • commenter
    doug estadt
    Jul 23 11:49 AM
    My Website
    Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [view article]
    I believe Durect - ticker drrx -are working on the same problem - abuse of Oxycodone and again - I believe - they expect to receive FDA approval in the winter if I'm not mistaken, for their offering to provide the same pain relief in a difficult-to-abuse formula. Reply
  • commenter
    MSmailbox
    Jul 22 03:44 AM
    Gannon On Investing's July 2008 Blogger Roundtable [view article]
    With the DJIA trading near it's 50-min highs, I am very BULLISH, going into Tuesday. I look for the market to continue setting new highs, over the next few hours... Long-term, into the late-morning, I expect some profit-taking, as investors lock-in profits. By afternoon, I believe that this BULL will continue to run, setting more new 50-min highs, but a lot can happen in four hours, so I'm keeping an eye on the exit. I used to "buy and hold," allowing certain positions to carry over from one day to the next, but since January of this year, I've found that to be rather unprofitable. My portfolio is up over 30% YTD, even though I've lost about 5%, since July 1. Today, I'll be watching to see if the action in solar and fertilizer stocks, continues. Yesterday, some performed very nicely, but that was yesterday, so I'll be looking into other sectors, as well. I *still* think that solar, fertilizer and materials are part of a bullish mega-trend, which could continue for a very long time, perhaps, even into next week! That will afford many opportunities to trade in and out, as they continue to climb, albeit unevenly. It's almost 6 hours until the markets reopen, so I intend to take a well-deserved vacation, then get up early to read the news. The future is very bright, if you can just ignore the flickering. Reply
  • commenter
    Calvin C.
    Jul 21 03:23 PM
    Gannon On Investing's July 2008 Blogger Roundtable [view article]
    These guys are shortsighted Reply
  • commenter
    carlita74
    Jul 06 02:28 PM
    Industries to Avoid, Industries to Buy [view article]
    since we are in a global economy ,whatever happens in China will be felt in the US and viceversa ,at some point in the future the standard of living in China will be close to that in the US ,their standard of living will certainly improve ,think about it you will be able to solve a big piece of this puzzle Reply
  • commenter
    paulk8756
    Jul 01 09:32 AM
    S&P 500 Stocks Furthest Above and Below Their 50-Day Moving Averages [view article]
    Gee, virtually all energy stocks. How about that. Reply
  • commenter
    theinvesting
    speculator
    Jul 01 07:39 AM
    My Website
    S&P 500 Stocks Furthest Above and Below Their 50-Day Moving Averages [view article]
    I don't think the S&p 500 will see 1400 again this year. Over the weekend Peter Schiff spoke to Barron's. He thinks the U.S is in trouble. There will always be good stock in any market, but most people will lose in declining market. Investing in foriegn markets is best. Reply
  • commenter
    fatcat
    Jun 30 07:59 PM
    S&P 500 Stocks Furthest Above and Below Their 50-Day Moving Averages [view article]
    Another couple of scary charts...I think I'm in the 70s... Reply
Loading...
Symbols:
Authors:
Quick Links: